返回 Agenda
Pharmacovigilance 2.0: Redesigning for the Future
Session Chair(s)
Annette S. Williams, MBA, RPH
Vice President, Pharmacovigilance
IQVIA, United States
Pharmacovigilance is a highly regulated environment with defined requirements for compliance and quality. The rapidly evolving world of artificial intelligence and machine learning has been applied to many industries with much success. How can these technological advances be applied to pharmacovigilance? Do they have a place in pharmacovigilance? Can they truly deliver the 3 C's: control, consistency, and cost savings? Real world examples will presented where these innovations are already in use, the difficulties encountered, and how organizations are harnessing the art of the possible.
Learning Objective : Describe available automation and artificial intelligence technologies; Discuss where these innovations are being applied; Describe tools to assess organizational readiness for this major redesign.
Speaker(s)
Pharmacovigilance and the Promise of Artificial Intelligence
Annette S. Williams, MBA, RPH
IQVIA, United States
Vice President, Pharmacovigilance
Information Technology Innovation in R&D: One Company's Journey, So Far
Robert A. Taylor
Merck & Co., Inc., United States
Director, Safety Systems Management
Unlocking Incredible Value in Safety Databases Together: The Platform Opportunity
Sundeep Surendra Sethi, MD, MBA
AbbVie, Inc., United States
Vice President, Safety Operations
Pharmacovigilance Innovation
Glenn Carroll, MBA
Deloitte, United States
Principal